DUBLIN, Feb. 11, 2021 /PRNewswire/ -- The "Erythropoietin (EPO) Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering. This report ...

The Erythropoietin (EPO) drugs market is a vital segment of the pharmaceutical industry that focuses on the development and distribution of medications aimed at stimulating red blood cell production.

Major players in the erythropoietin (EPO) market are Amgen Inc. , Johnson & Johnson, Roche Group, Pfizer Inc. , Novartis, Celltrion Inc, and LG Life Sciences Ltd. The global erythropoietin (EPO ...

Major players in the erythropoietin (EPO) market are Amgen Inc., Johnson & Johnson, Roche Group, Pfizer Inc., Novartis, Celltrion Inc and LG Life Sciences Ltd. The global erythropoietin (EPO) market ...

The global erythropoietin (EPO) drugs market is expected to reach USD 17.4 billion by 2025, according to a new report by Grand View Research, Inc. Rising incidence of chronic diseases such as CKD ...

The latest research study from MarketResearch.Biz with the title global Erythropoietin (EPO) Drugs Market is disclosed. The research report gives a complete estimation of the market and contains the ...

Amgen Inc. is recalling certain lots of anemia drugs Epogen and Procrit, sold by Johnson & Johnson, because they may contain "extremely thin" glass flakes that are barely visible. The recall ...

Development of anti-erythropoietin antibodies may result in pure red cell aplasia and severe anemias, according to the FDA.

Erythropoietin (EPO) is a hormone predominantly produced in the kidney, which is then released into blood. Erythropoietin promotes the production of red blood cells (erythropoiesis) in the bone ...